Travoprost
Back to searchMolecule Structure
Scientific Name
Travoprost
Description of the Drug
Travoprost is a prostaglandin analog used in the treatment of elevated intraocular pressure due to open angle glaucoma or ocular hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00287
http://www.drugbank.ca/drugs/DB00287
Brand Name(s)
Izba, Travatan, Travatan z, Travoprost
Company Owner(s)
Micro Labs Ltd, Apotex Inc, Alembic Pharmaceuticals Ltd, Alcon Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Strides Pharma Global Pte Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Prostanoid FP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1987 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL93818 | |
PharmGKB | PA164781371 | |
Human Metabolome Database | HMDB0014432 | |
DrugBank | DB00287 | |
PubChem: Thomson Pharma | 14884338 | 14933310 |
PubChem | 5282226 | |
LINCS | LSM-45593 | |
Nikkaji | J1.152.432J | |
BindingDB | 50248302 | |
EPA CompTox Dashboard | DTXSID80896948 | |
DrugCentral | 2716 | |
ChemicalBook | CB5703458 | |
Guide to Pharmacology | 7102 | |
rxnorm | TRAVATAN | TRAVOPROST |
PubChem: Drugs of the Future | 12015307 | |
ChEBI | 746859 | |
ZINC | ZINC000004474682 |